Table 1 Characteristics of the patients and their major comorbidities

From: Observational study of people infected with SARS-Cov-2, treated with amantadine

Variable	Patients n = 15
Age (years), mean ± SD	48.2 ± 16.62 (20–82)
Gender, n (%)
Male	5 (33.3)
Female	10 (66.6)
Major comorbities n (%)
Obesity	1 (6.6)
Hypertension	4 (26.6)
Cardiac disease	1 (6.6)
Diabetes mellitus	3 (20)
Renal disease	0 (0)
Asthma	0 (0)
Pulmonary disease	0 (0)

Back to article page